Clinical Trial Update: SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC [Phase 3]

View source ↗

Summary

Phase 3 randomized trial in HIV infection comparing tipRanavir/r with therapeutic drug monitoring (TDM) versus standard of care was terminated; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• tipRanavir/r (tipRanavir/r)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: TERMINATED | Results posted: 2009-11-26